Terms: = Germ cell tumor AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
38 results:
1. Recurrence Patterns and Surveillance Imaging in Pediatric Brain tumor Survivors.
Cacciotti C; Lenzen A; Self C; Pillay-Smiley N
J Pediatr Hematol Oncol; 2024 Apr; 46(3):e227-e232. PubMed ID: 38447113
[TBL] [Abstract] [Full Text] [Related]
2. A pyroptosis gene-based prognostic model for predicting survival in low-grade glioma.
Wang H; Yan L; Liu L; Lu X; Chen Y; Zhang Q; Chen M; Cai L; Dai Z
PeerJ; 2023; 11():e16412. PubMed ID: 38025749
[TBL] [Abstract] [Full Text] [Related]
3. Automated Brain tumor Detection and Segmentation for treatment Response Assessment Using Amino Acid PET.
Gutsche R; Lowis C; Ziemons K; Kocher M; Ceccon G; Régio Brambilla C; Shah NJ; Langen KJ; Galldiks N; Isensee F; Lohmann P
J Nucl Med; 2023 Oct; 64(10):1594-1602. PubMed ID: 37562802
[TBL] [Abstract] [Full Text] [Related]
4. Pediatric Optic Pathway Gliomas Resource Utilization and Prevalence in the OptumLabs Data Warehouse.
Stoddard-Bennett TN; Yu F; Spiegel SJ; Perez CF; Coleman AL; Repka MX; Pineles SL
J Neuroophthalmol; 2024 Mar; 44(1):10-15. PubMed ID: 37505911
[TBL] [Abstract] [Full Text] [Related]
5. Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas.
Ye L; Tong S; Wang Y; Wang Y; Ma W
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9857-9876. PubMed ID: 37248320
[TBL] [Abstract] [Full Text] [Related]
6. Outcomes of Children With Low-Grade Gliomas in Low- and Middle-Income Countries: A Systematic Review.
Ward R; Jones HM; Witt D; Boop F; Bouffet E; Rodriguez-Galindo C; Qaddoumi I; Moreira DC
JCO Glob Oncol; 2022 Oct; 8():e2200199. PubMed ID: 36198134
[TBL] [Abstract] [Full Text] [Related]
7. The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression.
Kim CM; Lee JB; Shin SJ; Ahn JB; Lee M; Kim HS
ESMO Open; 2022 Oct; 7(5):100577. PubMed ID: 36156450
[TBL] [Abstract] [Full Text] [Related]
8. Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.
Tew A; Khoja L; Pallan L; Steven N
J Oncol Pharm Pract; 2023 Jul; 29(5):1163-1171. PubMed ID: 35607278
[TBL] [Abstract] [Full Text] [Related]
9. Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 children.
Bansal R; Aishwarya A; Rao R; Christy MC; Sen M; Regani H; Bagai P; Reddy VA; Mulay K; Bongoni P; Honavar SG
Indian J Ophthalmol; 2021 Oct; 69(10):2617-2624. PubMed ID: 34571599
[TBL] [Abstract] [Full Text] [Related]
10. treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review.
Wei LD; Li C; Li D; Liu XJ; Li RT; Li LW; Wang JM; Zhou DB
Pituitary; 2021 Oct; 24(5):754-767. PubMed ID: 33982223
[TBL] [Abstract] [Full Text] [Related]
11. The sodium pump α1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway.
Lan YL; Zou YJ; Lou JC; Xing JS; Wang X; Zou S; Ma BB; Ding Y; Zhang B
Cell Biol Toxicol; 2019 Dec; 35(6):521-539. PubMed ID: 30739221
[TBL] [Abstract] [Full Text] [Related]
12. Survival Analysis of Glioblastoma Multiforme.
Witthayanuwat S; Pesee M; Supaadirek C; Supakalin N; Thamronganantasakul K; Krusun S
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2613-2617. PubMed ID: 30256068
[TBL] [Abstract] [Full Text] [Related]
13. Burst and continuous high frequency irreversible electroporation protocols evaluated in a 3D tumor model.
Sano MB; Fesmire CC; DeWitt MR; Xing L
Phys Med Biol; 2018 Jul; 63(13):135022. PubMed ID: 29978834
[TBL] [Abstract] [Full Text] [Related]
14. Temporal trends in management and outcomes of testicular cancer: A population-based study.
Leveridge MJ; Siemens DR; Brennan K; Izard JP; Karim S; An H; Mackillop WJ; Booth CM
Cancer; 2018 Jul; 124(13):2724-2732. PubMed ID: 29660851
[TBL] [Abstract] [Full Text] [Related]
15. Bufalin inhibits glioblastoma growth by promoting proteasomal degradation of the Na
Lan YL; Wang X; Lou JC; Xing JS; Yu ZL; Wang H; Zou S; Ma X; Zhang B
Biomed Pharmacother; 2018 Jul; 103():204-215. PubMed ID: 29653366
[TBL] [Abstract] [Full Text] [Related]
16. Marinobufagenin inhibits glioma growth through sodium pump α1 subunit and ERK signaling-mediated mitochondrial apoptotic pathway.
Lan YL; Wang X; Lou JC; Xing JS; Zou S; Yu ZL; Ma XC; Wang H; Zhang B
Cancer Med; 2018 May; 7(5):2034-2047. PubMed ID: 29582577
[TBL] [Abstract] [Full Text] [Related]
17. Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
Coens C; Suciu S; Chiarion-Sileni V; Grob JJ; Dummer R; Wolchok JD; Schmidt H; Hamid O; Robert C; Ascierto PA; Richards JM; Lebbé C; Ferraresi V; Smylie M; Weber JS; Maio M; Bottomley A; Kotapati S; de Pril V; Testori A; Eggermont AMM
Lancet Oncol; 2017 Mar; 18(3):393-403. PubMed ID: 28162999
[TBL] [Abstract] [Full Text] [Related]
18. The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma.
Bernard-Arnoux F; Lamure M; Ducray F; Aulagner G; Honnorat J; Armoiry X
Neuro Oncol; 2016 Aug; 18(8):1129-36. PubMed ID: 27177573
[TBL] [Abstract] [Full Text] [Related]
19. Circular RNA profile in gliomas revealed by identification tool UROBORUS.
Song X; Zhang N; Han P; Moon BS; Lai RK; Wang K; Lu W
Nucleic Acids Res; 2016 May; 44(9):e87. PubMed ID: 26873924
[TBL] [Abstract] [Full Text] [Related]
20. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.
Eggermont AM; Chiarion-Sileni V; Grob JJ; Dummer R; Wolchok JD; Schmidt H; Hamid O; Robert C; Ascierto PA; Richards JM; Lebbé C; Ferraresi V; Smylie M; Weber JS; Maio M; Konto C; Hoos A; de Pril V; Gurunath RK; de Schaetzen G; Suciu S; Testori A
Lancet Oncol; 2015 May; 16(5):522-30. PubMed ID: 25840693
[TBL] [Abstract] [Full Text] [Related]
[Next]
